Leadership, Planning, and Evaluation

摘要、领导力、规划和评估 印第安纳州大学梅尔文和布伦西蒙癌症中心（IUSCC）已经建立了一个有效的过程， 领导、规划和评估，接受其高级领导、项目领导和 成员以及内部和外部咨询委员会。根据这一投入， 制定了战略计划，实施了这一计划，并定期评估其对四项研究的影响。 计划和多个共享资源（核心）推进我们的使命，为印第安纳州的公民服务， 超越。IUSCC战略计划于2018年更新，有四大研究支柱：生物学， 床边转化研究，精准医学，人口健康（重点是预防，早期 检测和卫生保健差异），生存和症状科学。根据这一战略计划， 根据我们顾问的反馈，高级领导层在过去一年中实施了一系列行动， 资助期间包括：1）解散乳腺癌计划，并将其成员纳入剩余的 基础和转化研究计划; 2）任命转化研究副院长; 3） 在癌症预防和控制（CPC）以及实验和发展方面建立新的领导层 治疗学（EDT）计划; 4）重新命名造血，血液肿瘤和免疫学（HMI） 计划造血和血液肿瘤（HHM），以强调其重点是“液体肿瘤”， 认识到癌症免疫学贯穿所有计划; 5）创建社区外展办公室 和参与，以推动我们在整个国家的活动; 6）正式建立肿瘤微环境 和转移（TMM）和HHM计划作为基础研究计划; 7）开发新的癌症 生物信息学和转化研究核心;以及8）整合了IUSM的蛋白质组学和基因组学核心 在IUSCC。根据我们战略计划的主题支柱，这些变化推动了IUSCC的使命 通过支持团队科学，扩大 社区外展和参与活动，并扩大我们的教育足迹以激励下一个 一代癌症研究者。

ABSTRACT, Leadership, Planning and Evaluation The Indiana University Melvin and Bren Simon Cancer Center (IUSCC) has established an effective process for Leadership, Planning and Evaluation that receives input from its Senior Leaders, Program Leaders and Membership as well as internal and external advisory committees. Based on this input, the IUSCC leadership has molded its strategic plan, implemented this plan, and regularly evaluates its impact on its four Research Programs and multiple Shared Resources (Cores) advancing our mission to serve the citizens of Indiana and beyond. The IUSCC Strategic Plan, which was updated in 2018, has four major research pillars: Biology to Bedside Translational Research, Precision Medicine , Population Health (with an emphasis on Prevention, Early Detection and Health Care Disparities), and Survivorship and Symptom Science. Following this strategic plan and with feedback from our advisors, the Senior Leadership implemented a number of actions during the last funding period including: 1) dissolving the Breast Cancer Program and integrated its members into the remaining basic and translational research programs; 2) appointing an Associate Dean of Translational Research; 3) installing new leadership in the Cancer Prevention and Control (CPC) and the Experimental and Developmental Therapeutics (EDT) Programs; 4) renaming Hematopoiesis, Hematologic Malignancies and Immunology (HMI) Program to Hematopoiesis and Hematologic Malignancies (HHM) to emphasize its focus on “liquid tumors” and recognizing that cancer immunology cuts across all programs; 5) creating the Office of Community Outreach and Engagement to drive our activities throughout the state; 6) formally establishing the Tumor Microenvironment and Metastasis (TMM) and HHM programs as basic research programs; 7) developed new Cancer Bioinformatics and Translational Research cores; and 8) integrated the IUSM's Proteomics and Genomics Cores with the IUSCC. These changes, informed by the thematic pillars of our strategic plan, drive the IUSCC's mission to impact research, patient care and education both locally and globally by bolstering team science, amplifying community outreach and engagement activities and expanding our educational footprint to inspire the next generation of cancer researchers.